Outcomes and characteristics of COVID-19 patients treated with continuous positive airway pressure/high-flow nasal oxygen outside the intensive care setting.
Dominic L SykesMichael G CrooksKhaing Thu ThuOliver Ian BrownTheodore J P TyrerJodie RennardsonCatherine LittlefieldShoaib FaruqiPublished in: ERJ open research (2021)
CPAP and HFNO delivered outside of the intensive care setting are viable treatment options for patients with hypoxaemic respiratory failure secondary to COVID-19 pneumonia, including those considered unsuitable for invasive mechanical ventilation. This provides an opportunity to safeguard intensive care capacity for COVID-19 patients requiring invasive mechanical ventilation.
Keyphrases
- mechanical ventilation
- respiratory failure
- positive airway pressure
- sars cov
- obstructive sleep apnea
- coronavirus disease
- acute respiratory distress syndrome
- intensive care unit
- sleep apnea
- extracorporeal membrane oxygenation
- respiratory syndrome coronavirus
- metabolic syndrome
- adipose tissue
- chronic rhinosinusitis